WHO ICTRP trial
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung…
ISRCTN70127774 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN70127774 |
|---|---|
| Public title | Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP) |
| Scientific title | Hydroxymethylglutaryl-CoA reductase inhibition in Acute lung injury to Reduce Pulmonary oedema and inflammation: a phase II, single centre, prospective, double-blind, randomised, placebo-controlled trial |
| Primary sponsor | The Royal Group Hospitals Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) Respiratory Acute lung injury and acute respiratory distress syndrome (ARDS) |
| Interventions | Patients will be stratified for the presence of severe sepsis as a clinical risk factor for the development of acute lung injury. Stratified block randomisation using a microcomputer to simvastatin 80 mg or placebo enterally (1:1) will be… |
| Registration date | Apr 24, 2006 |
| Target size | 60 |
| Secondary IDs | EME 08/99/08; RGHT000275 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: